Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

27.28
Delayed Data
As of Sep 23
 +0.06 / +0.22%
Today’s Change
23.59
Today|||52-Week Range
43.63
-36.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues148.2M130.9M115.9M127.5M
 
 
 
 
 
Cost of Goods Sold21.2M22.7M19.4M20.6M
 
 
 
 
 
Depreciation And Amortization3.7M3.9M3.9M6.0M
 
 
 
 
 
 
Operating ExpensesGross Income123.3M104.3M92.6M100.9M
 
 
 
 
 
General Expenses94.4M97.0M96.4M105.7M
 
 
 
 
 
Research And Development43.4M44.0M44.6M50.3M
 
 
 
 
 
Total Operating Expenses119.3M123.5M119.7M132.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income28.9M7.4M-3.8M-4.8M
 
 
 
 
 
Extraordinary Credit0.000.0010.3M--
 
 
Extraordinary Charge-3.2M-3.5M-13.4M-9.2M
 
 
 
 
 
Interest Expense On Debt4.0M3.4M3.7M4.0M
 
 
 
 
 
Other Expenses-59.0K0.00142.0K-1.9M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income21.7M655.0K-10.3M-19.9M
 
 
 
 
 
Income Taxes-17.8M-8.6M-9.7M-972.0K
 
 
 
 
 
Minority Interest0.000.000.00-678.0K
 
 
Net Income3.9M9.2M-520.0K-18.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.2M42.6M44.8M45.3M
 
 
 
 
 
Shares To Calculate EPS Diluted43.4M44.2M44.8M45.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.09$0.21-$0.01-$0.40
 
 
 
 
 
EPS Diluted$0.09$0.21-$0.01-$0.40